Not really. Short-term (a few days) impact of the failure of cvm on nwbo price - everybody has seen it now
med-term (within week) impact -- favorable for nwbo price appreciation
Long-term impact - none
only explain the first one - sympathy price drop understandable as most investors particularly non-investors who are considering and about to take a position are ignorant and have not done their DD yet. after some digging and digesting, actually those undecided or those who may be panic and sold some shares will finally realize
1) Multikine and DCVax-L are actually two different beasts
2) NWBio will be most likely meeting its primary and key secondary endpoints
3) the worst scenario for nwbo price drop if ever it would fail in its trial not meeting its primary endpoint like CVM is in the worst case 40%, not really that much expected by most investors
As a matter of fact, NWBio will probably meet its primary and key secondary endpoints
[conclusion:} new blood will flow into nwbo within days]
Market Data 
Markets 
AI
